Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, a significant proportion of the MDS population will be left underserved by pharmacotherapy.
Published By Datamonitor
|
18 Oct 2005 |
$1900
|
Report
|
Overview of the current prostate cancer clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2018, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
14 Aug 2009 |
$11400
|
Report
|
Primary research-based analysis of the chronic leukemias market. Includes patient segmentation, treatment trends, prescribing influences and brand perception.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
Report
|
Overview of the current colorectal cancer clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2018, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
21 Oct 2009 |
$11400
|
Report
|
Comprehensive analysis of the gene therapy clinical pipeline across all geographic and therapeutic markets, with key opinion leader insights. Identification of drivers and inhibitors to the commercial success of gene therapy.
Published By Datamonitor
|
10 Dec 2009 |
$3800
|
Report
|
Primary research-based analysis of the non-Hodgkin's lymphomas market, including epidemiology, patient segmentation, and treatment data. Separate coverage of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Published By Datamonitor
|
17 Dec 2009 |
$15200
|
Report
|
Datamonitor surveyed 180 oncologists, anesthetists, palliative medicine specialists and pain care specialists in the seven major markets to gain insight into cancer pain prevalence, treatment trends and key prescribing influences.
Published By Datamonitor
|
23 Dec 2009 |
$15200
|
Report
|
Overview of the current biologic molecular targeted therapies pipeline in oncology, including analysis of late-phase products, clinical trial data, sales forecasts through to 2018, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
24 Dec 2009 |
$11400
|
Report
|
Key issues in the gynecological malignancies market, focusing mainly on endometrial and cervical cancer, including forecast epidemiology, current treatment trends and controversies, unmet needs, insight into pipeline activity and stakeholder opinion.
Published By Datamonitor
|
17 Mar 2010 |
$3800
|
Report
|
Overview of the current gastrointestinal cancers clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2019, Datamonitor drug assessment summaries and key opinion leader insight.
Published By Datamonitor
|
25 Mar 2010 |
$11400
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.